Marie-Claude Dubois

Moderniserad dagsljusstandard : Report SBUF ID 13209

Paul Rogers, Max Tillberg, Marie-Claude Dubois, 2018 .

Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children.

Inácio Mandomando, Marie-Claude Dubois, Quique Bassat, 2009, The Journal of infectious diseases.

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.

Marie-Claude Dubois, Janet Wittes, J. Wittes, 2007, Vaccine.

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

Inacio Mandomando, Bart Spiessens, Mateu Espasa, 2004, The Lancet.

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.

V. A. Stewart, Marie-Claude Dubois, In-Kyu Yoon, 2010, Vaccine.